Hipotensiôn ortostâtica: Diagnöstico y tratamiento

Revista de Neurologia

Volumn 25, Issue 137, 1997, Pages 115-119

  Benarroch, E E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDROCORTISONE ACETATE; MIDODRINE; PHENYLPROPANOLAMINE; ANTIDIABETIC AGENT; ARGIPRESSIN[1 DEAMINO]; FLUDROCORTISONE; HORMONE; OCTREOTIDE;

ALCOHOLISM; AMYLOIDOSIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONFERENCE PAPER; DIABETES MELLITUS; GUILLAIN BARRE SYNDROME; ORTHOSTATIC HYPOTENSION; PARANEOPLASTIC SYNDROME; PATIENT EDUCATION; SJOEGREN SYNDROME; DIET THERAPY; EXERCISE; HUMAN; REVIEW; RISK FACTOR; VALSALVA MANEUVER;

DEAMINO ARGININE VASOPRESSIN; DIET THERAPY; EXERCISE; FLUDROCORTISONE; HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; HYPOTENSION, ORTHOSTATIC; OCTREOTIDE; RISK FACTORS; VALSALVA MANEUVER;

EID: 0030885002     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Consensus Committee of the American Autonomie Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomie failure, and multiple system atrophy. Neurology 1966; 46: 1470.
2. Mathias CJ. Orthostatic hypotension. Causes, mechanisms, and influencing factors. Neurology 1995; 45 (Suppl 5): S6-S11.
3. Mathias CJ, Bannister R. Investigation of autonomie disorders. En Bannister R, Mathias CJ, eds. Autonomie Failure: a textbook of autonomie disorders of the nervous system. 3 ed. Oxford: Oxford Univ Press, 1992;255-290.
4. Low PA. Clinical evaluation of autonomie function. En Low PA, ed. Clinical autonomie disorders: evaluation and management. Boston: Little Brown, 1993; 157-167.
5. Robertson D, Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995; 45 (Suppl 5): S26-S32.
6. Low PA. Laboratory evaluation of autonomie function. En Low PA, ed. Clinical autonomie disorders: evaluation and management. Boston: Little Brown 1993; 169-195.
7. Fealey RD, Robertson D. Management of orthostatic hypotension. En Low PA, ed. Clinical autonomie disorders: evaluation and management. Boston: Little Brown, 1993; 731-746.
8. Freeman R, Miyawaki E. The treatment of autonomie dysfunction. J Clin Neurophysiol 1993; 10: 61-82.
9. Low PA. Neurogenic Orthostatic Hypotension. En Johnson R, ed. Current therapy in neurologic disease, 1994; 21-26.
10. Onrot J, Goldberg BR, Biaggioni I, et al. Hemodynamic and humoral effects of caffeine in autonomie failure. Therapeutic implications for postprandial hypotension. N Eng J Med 1985; 313: 549-554.
11. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvers that reduce postural hypotension in autonomie failure. Clin Auton Res 1993;3:57-66.
12. Campbell I\V, Ewing DJ, Clarke BF. 9-α-fiuorohydrocortisone in the treatment of postural hypotension in diabetic neuropathy. Diabetes 1975; 24:381-384.
13. Biaggioni I, Onrot J, Stewart CK, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomie impairment. JAMA 1987; 258: 236-239.
14. McTavish D, Goa KL. Midodrine: a review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 1989; 38: 757-777.
15. Biaggioni I, Zygmunt D, Haile V, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol 1990; 65: 89-92.
16. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoyetin. N Eng J Med 1993; 329: 611-615.
17. Mathias CJ, Fosbraey P, da Costa DF, et al. The effect of desmopressin on nocturnal polyuria, overnight weight loss and morning postural hypotension in patients with autonomie failure. Br Med J-Clin Res 1986; 293: 353-354.
18. Hoedtke RD, Israel BC. Treatment of orthostatic hypotension with octreotide. J Clin Endocrinol Metab 1989; 68: 1051-1059.
19. Freeman R, Landsberg L. The treatment of orthostatic hypotension with dihydroxyphenylserine. Clin Neuropharmacol 1991; 14: 296-304.
20. Kochar MS, Itskovitz HD. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1978; 1: 1011-1014